Effects of SGLT2 inhibitors on gout-related and cardiometabolic outcomes in patients with type 2 diabetes mellitus: a scoping review

Advances in Rheumatology · Published 2026-07-24 · DOI 10.1186/s42358-026-00564-w

Free full text

Authors (3)

Henrique Pereira Sampaio, Barbara Casarin Henrique-Sanches, Carlos Antonio Negrato

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Sampaio, H., Henrique-Sanches, B., Negrato, C. (2026). Effects of SGLT2 inhibitors on gout-related and cardiometabolic outcomes in patients with type 2 diabetes mellitus: a scoping review. Advances in Rheumatology. https://doi.org/10.1186/s42358-026-00564-w

Related articles

• Psychosocial and behavioral correlates of persistent pain post disease-modifying treatment change in rheumatoid arthritis: a 12-month cohort study · Advances in Rheumatology · 2026 · Same journal
• Comparative analysis of conventional and novel inflammatory biomarkers in Familial Mediterranean fever during attack-free periods · Advances in Rheumatology · 2025 · Same journal
• Correlation between body mass index and disease activity in patients with systemic lupus erythematosus from China · Advances in Rheumatology · 2025 · Same journal
• Exploring somatosensory temporal discrimination deficits in rheumatoid arthritis: associations with disease activity and functionality · Advances in Rheumatology · 2025 · Same journal
• Brazilian Society of Rheumatology – 2025 recommendations on vaccination in immune-mediated rheumatic diseases · Advances in Rheumatology · 2026 · Same journal
• Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohort · Advances in Rheumatology · 2025 · Same journal
• Hyperinflammatory status associated with COVID-19: clinical features of a pediatric series · Advances in Rheumatology · 2025 · Same journal
• Brazilian Society of Rheumatology’s fibromyalgia treatment guidelines – part I: monitoring and non-pharmacological management · Advances in Rheumatology · 2026 · Same journal
• Are global definitions enough? Revisiting CDAI and SDAI remission cut-offs in Brazilian Rheumatoid Arthritis patients · Advances in Rheumatology · 2026 · Same journal
• Vascular endothelial growth factor (VEGF) biology and its proposed role in rheumatic diseases pathogenesis · Advances in Rheumatology · 2026 · Same journal